<code id='833B97EB97'></code><style id='833B97EB97'></style>
    • <acronym id='833B97EB97'></acronym>
      <center id='833B97EB97'><center id='833B97EB97'><tfoot id='833B97EB97'></tfoot></center><abbr id='833B97EB97'><dir id='833B97EB97'><tfoot id='833B97EB97'></tfoot><noframes id='833B97EB97'>

    • <optgroup id='833B97EB97'><strike id='833B97EB97'><sup id='833B97EB97'></sup></strike><code id='833B97EB97'></code></optgroup>
        1. <b id='833B97EB97'><label id='833B97EB97'><select id='833B97EB97'><dt id='833B97EB97'><span id='833B97EB97'></span></dt></select></label></b><u id='833B97EB97'></u>
          <i id='833B97EB97'><strike id='833B97EB97'><tt id='833B97EB97'><pre id='833B97EB97'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:96
          Cigna logo
          Julia Rendleman/Getty Images for Eventive Marketing

          Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

          The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

          advertisement

          That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          ASCO Daily Recap: Safety data from Novartis, survival from Pfizer
          ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

          ADAMFEUERSTEIN/STATYou’rereadingthewebeditionofASCOin30Seconds,STAT’sguidetotheAmericanSocietyofClin

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          For one rare type of lung cancer, Pfizer pill reduces progression by 81%

          AP/BusinessWireTherearealotofreasonswhyupdateddataonPfizer’sLorbrena,atreatmentfornon-smallcelllungc